Semaglutide Sodium
Semaglutide Sodium (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), a long-acting glucagon-like peptide 1 (GLP-1) analogue, is a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM).
Trivial name | Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217 |
Catalog Number | E7333 |
Molecular Formula | C6H8ClN7O.HCl |
CAS# | 910463-68-2(free base) |
Inchi | InChI=1S/C6H8ClN7O.ClH/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11;/h(H4,8,9,13)(H4,10,11,14,15);1H |
Inchi Key | ACHKKGDWZVCSNH-UHFFFAOYSA-N |
SMILES | C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl |
Size | 1mg |
Supplier Page | http://www.selleckchem.com/products/semaglutide-sodium.html |
Additional Information | https://file.selleck.cn/downloads/struct/e7333-semaglutide-chemical-structure-tube.png |